Kanjinti® (trastuzumab-anns)
for Gastric Cancer Stomach Cancer

Kanjinti (trastuzumab-anns) is used to treat certain types of breast or stomach cancer, often in combination with other cancer treatments. It is also used for metastatic cancer, where the cancer has spread to other parts of the body. Kanjinti works by stopping the growth of cancer cells that express high levels of the HER2 protein. Your cancer cells can be tested to determine if trastuzumab is an appropriate treatment option for you.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Gastric Cancer - Stomach Cancer